Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

about

Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

Item

http://www.wikidata.org/entity/Q41487374

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

@en

type

Item

label

Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

@en

prefLabel

Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

@en

P1476

Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis

@en

P2093

Berrak Yetimler

http://www.w3.org/2001/XMLSchema#string

Erdem Tüzün

http://www.w3.org/2001/XMLSchema#string

Hacer Durmuş

http://www.w3.org/2001/XMLSchema#string

Hatice Taşli

http://www.w3.org/2001/XMLSchema#string

Murat Giriş

http://www.w3.org/2001/XMLSchema#string

Yeşim Parman

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis.

Polymyositis and dermatomyositis (first of two parts).

Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase.

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.

IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells

Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission.

The role of inflammatory cytokines in endothelial dysfunction

The Clinical and Histological Spectrum of Idiopathic Inflammatory Myopathies.

Immunization of mice with T cell-dependent antigens promotes IL-6 and TNF-alpha production in muscle cells.

Preferential infiltration of interleukin-4-producing CXCR4+ T cells in the lesional muscle but not skin of patients with dermatomyositis.

P304

657-660

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21873/INVIVO.11108

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28652434

http://www.w3.org/2001/XMLSchema#string

P921

dermatomyositis

P932

5566917

http://www.w3.org/2001/XMLSchema#string